MEF2 negatively regulates learning-induced structural plasticity and memory formation
Despite promising results showed by pre-clinical studies, anti-VEGF monotherapy such as bevacizumab, sunitinib and aflibercept among others have only provided limited benefits in certain tumor types including advanced-stage renal cell carcinoma, hepatocellular carcinoma and colorectal carcinoma and have not shown efficacy in pancreatic adenocarcinoma, prostate cancer, breast cancer or melanoma [287]
Globally, millions face vision loss due to conditions like cataracts, glaucoma, and retinal diseases
The synapse proteome and phosphoproteome: a new paradigm for synapse biology
Clinical disease in humans can be divided into acute and chronic manifestations
At Cymbiotika, we believe in transparency and empowering you with the knowledge to manage your wellness